CAD Clinical Trial
Official title:
Aspirin Responsiveness in Women With Coronary Artery Disease
Verified date | August 2012 |
Source | Creighton University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The purpose of this study is to measure the percentage of women with known Coronary Artery Disease (CAD) who are hyporesponsive to low dose (81 mg) aspirin.
Status | Completed |
Enrollment | 15 |
Est. completion date | April 2012 |
Est. primary completion date | April 2012 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 45 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Able and willing to provide informed consent - Women at least 45 years old of any race - Taking 81 mg aspirin daily, for at least one month - Diagnosed with known or suspected CAD with at least one of the following: angiographic evidence of at least one lesion > 50% stenosis, history of significant elevation of biomarker troponin or CK-MB, or history of ECG changes in at least 2 contiguous leads characterized by either new ST depression > 0.1 mV or transient (<30 min) ST elevation > 0.1 mV, coronary artery revascularization either by PCI or CABG Exclusion Criteria: - < 45 years or > 85 years of age - Clinically unstable: hypotension defined as sustained systolic blood pressure of <90 mmHg due to cardiac failure with associated symptoms, unstable or severe pulmonary edema, decompensated congestive heart failure, acute mitral regurgitation, acute ventricular septal defect, acute cerebrovascular event or transient ischemic attack (TIA) within the past six months, history of ventricular fibrillation and no implantable cardioverter defibrillator (ICD), sustained supraventricular tachycardia > 30 seconds or associated with symptoms and no ICD, untreated complete heart block or untreated high grade secondary heart block - Pregnant, planning to become pregnant, or breastfeeding - Alcohol abuse or illicit drug abuse - Allergy or intolerance to salicylates and/or excipients including a history of and/or active GI bleed - Use of NSAIDs within seven days or planned regular use during the study - Taking HRT or oral contraceptives within the past 30 days or planned use during study - Use of heparin, warfarin, ADP inhibitors (clopidogrel, prasugrel, or ticlopidine), or glycoprotein IIb/IIa inhibitors within previous 96 hours or planned use during the study - Use or planned use of any other medications known to interfere with AA-induced platelet function - Currently participating in another investigational drug or device study - Survival less than six months |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | The Cardiac Center at Creighton University | Omaha | Nebraska |
Lead Sponsor | Collaborator |
---|---|
Creighton University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Women With Known CAD Who Are Hyporesponsive to Low Dose (81 mg) Aspirin | Hyporesponsive was defined as Aspirin Response Unit (ARU) > 550 equating to less than 50% platelet inhibition. | Time of enrollment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04459299 -
CorPath GRX STEMI Study
|
||
Not yet recruiting |
NCT02853994 -
Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice
|
N/A | |
Completed |
NCT02440893 -
Understanding the Effect of Metformin on Corus CAD (or ASGES)
|
||
Completed |
NCT01486030 -
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
|
||
Recruiting |
NCT06239493 -
IVUS-Guided Treatment for Percutaneous Vascular Interventions
|
||
Recruiting |
NCT05344612 -
Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD
|
N/A | |
Terminated |
NCT03901079 -
Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions
|
||
Completed |
NCT02457455 -
Urgent Medical and Surgical Conditions During Flights
|
N/A | |
Recruiting |
NCT05509010 -
AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry
|
||
Completed |
NCT03930589 -
Remote Ischemic Conditioning in STEMI to Decrease Infarct Size
|
N/A | |
Completed |
NCT01251302 -
Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
|
||
Withdrawn |
NCT02158754 -
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
|
||
Completed |
NCT01949844 -
Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies
|
N/A | |
Recruiting |
NCT04787796 -
The Application of a Portable Multichannel ECG System for the Patients Suspected to Have Possible CAD or ACS
|
N/A | |
Recruiting |
NCT03894423 -
Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery
|
||
Completed |
NCT02223286 -
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
|
N/A | |
Completed |
NCT06154018 -
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
|
N/A | |
Completed |
NCT02132611 -
Coronary Orbital Atherectomy System Study
|
N/A | |
Completed |
NCT01402804 -
NSAIDs in Coronary Artery Disease Patients
|
N/A | |
Completed |
NCT00500617 -
Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree
|